1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Frost & Sullivan’s 2014 Life Sciences Outlook

Frost & Sullivan’s 2014 Life Sciences Outlook

  • April 2014
  • -
  • Frost & Sullivan
  • -
  • 26 pages

Summary

Table of Contents

In 2013, healthcare moved towards access, transparency, investments, and spending. In 2014, Frost & Sullivan anticipates new launches to occur across the life sciences spectrum, from preventive medicine to treating complex diseases. This market insight touches upon major events that occurred in 2013 and how 2014 is expected to shape up, including future investments, regulatory changes, and new launches. Key companies to watch are highlighted, and strategic recommendations are provided.


Executive Summary

The pharmaceutical/biotechnology industry is continuing to move away from the blockbuster
model approach and towards the treatment of orphan diseases and personalized medicine.

Continued growth in personalized medicine and companion diagnostics will move beyond
oncology and into areas such as virology, central nervous system, and cardiology.

While the number of new molecular entities (NMEs) continues to decline, the life sciences
industry has made great progress in treating complex conditions and providing greater ease
of use for patients (e.g., oral medicines for complex conditions such as hepatitis C and
multiple sclerosis).

The industry is seeing increasing speed and intensity of product competition in the areas of
generics and biosimilars, including the recent European launch of biosimilar monoclonal
antibodies (mAbs).

It is becoming the norm worldwide for payments and reimbursements to be tied to quality of
care.

Pharmaceutical companies continue to move beyond the pill. Big pharma companies are
looking to adopt alternative business models beyond prescription treatments to support the
entire continuum of care such as disease prevention and patient monitoring.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Versatile Innovation in Immunology - Large Therapy Area Pipeline with a High Degree of Repositioning Potential

Frontier Pharma: Versatile Innovation in Immunology - Large Therapy Area Pipeline with a High Degree of Repositioning Potential

  • $ 6995
  • Industry report
  • January 2017
  • by GBI Research

Frontier Pharma: Versatile Innovation in Immunology - Large Therapy Area Pipeline with a High Degree of Repositioning Potential Summary Immunology is a large therapy area characterized by disorders of ...

Frontier Pharma: Head and Neck Cancer - Immunotherapies and Signal Transduction Inhibitors Dominate First-in-Class Innovation

Frontier Pharma: Head and Neck Cancer - Immunotherapies and Signal Transduction Inhibitors Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • March 2017
  • by GBI Research

Frontier Pharma: Head and Neck Cancer - Immunotherapies and Signal Transduction Inhibitors Dominate First-in-Class Innovation Summary Head and neck cancer (HNC) is the sixth most common malignancy worldwide, ...

Medical Laboratory Testing Services including Cardiac, Molecular Diagnostic and Genomic. Strategies & Trends.  Price & Volume Forecasts by Laboratory Department. 2017 to 2022 -  Global Version

Medical Laboratory Testing Services including Cardiac, Molecular Diagnostic and Genomic. Strategies & Trends. Price & Volume Forecasts by Laboratory Department. 2017 to 2022 - Global Version

  • $ 5995
  • Industry report
  • April 2017
  • by Howe Sound Research

“Medical Laboratory Testing Services reaches 12 billion tests per year. Genomic technology and China healthcare expansion driving global growth.....” Report Overview: A market that just keeps on growing. ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.